icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Advancing Chronic Hepatitis Delta Therapy: Efficacy of Tobevibart (VIR-3434) + Elebsiran (VIR-2218) in Chronic Hepatitis Delta Infection
 

 
 
  IDSA 2026 Oct 21-24 Wash DC

1026261opy

1026262copy

1026263copy

1026264copy

1026265copy

1026266copy

1026267copy